GOLD CONCENTRATIONS IN BLOOD FRACTIONS OF PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH MYOCRISIN

被引:9
|
作者
EGILA, J
LITTLEJOHN, D
SMITH, WE
STURROCK, RD
机构
[1] UNIV STRATHCLYDE,DEPT PURE & APPL CHEM,THOMAS GRAHAM BLDG,295 CATHEDRAL ST,GLASGOW G1 1XL,SCOTLAND
[2] FED UNIV TECHNOL YOLA,DEPT CHEM,YOLA,NIGERIA
[3] UNIV GLASGOW,GLASGOW ROYAL INFIRM,DEPT MED,GLASGOW,SCOTLAND
关键词
GOLD; MYOCRISIN; SODIUM AUROTHIOMALATE; BLOOD CELLS; PLASMA; ATOMIC ABSORPTION SPECTROMETRY;
D O I
10.1016/0731-7085(92)80091-Z
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Gold levels in the plasma and blood cells of patients treated with the gold drug Myocrisin (sodium aurothiomalate) were determined by atomic absorption spectrometry. There is a correlation between whole blood gold and plasma gold concentrations which is different for smokers and non-smokers. Most cellular gold is associated with the membrane and is present in concentrations approximately equivalent to the number of reactive sulphydryl groups on the exofacial surface of the cell. Since gold would be expected to react with SH groups and since these groups are vital for cellular function, a possible role for gold in modifying cellular metabolism is indicated.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [1] RENAL INJURY IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH GOLD
    MERLE, LJ
    REIDENBERG, MM
    CAMACHO, MT
    JONES, BR
    DRAYER, DE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 216 - 222
  • [2] RENAL INJURY IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH GOLD
    DRAYER, DE
    MERLE, LJ
    CAMACHO, MT
    JONES, BR
    REIDENBERG, MM
    [J]. CLINICAL RESEARCH, 1980, 28 (02): : A235 - A235
  • [3] GOLD METABOLISM IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH GOLD COMPOUNDS - REINVESTIGATED
    MASCARENHAS, BR
    GRANDA, JL
    FREYBERG, RH
    [J]. ARTHRITIS AND RHEUMATISM, 1972, 15 (04): : 391 - +
  • [4] IMMUNOLOGICAL STUDIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING AZATHIOPRINE AND MYOCRISIN IN COMBINATION
    LEWIS, P
    HAZLEMAN, BL
    PARK, JR
    BULGEN, DY
    FRANKS, D
    HURD, C
    BROWN, DL
    [J]. CLINICAL RHEUMATOLOGY, 1982, 1 (03) : 168 - 175
  • [5] PROTEINURIA IN GOLD-TREATED RHEUMATOID-ARTHRITIS
    KATZ, WA
    BLODGETT, RC
    PIETRUSKO, RG
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (02) : 176 - 179
  • [6] GOLD-SPECIFIC T-CELLS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH GOLD
    ROMAGNOLI, P
    SPINAS, GA
    SINIGAGLIA, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01): : 254 - 258
  • [7] A PLACEBO-CONTROLLED CLINICAL AND LABORATORY COMPARISON OF AURANOFIN AND MYOCRISIN IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    LEWIS, D
    MCNEIL, C
    SMITH, WE
    CAPELL, HA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1982, 41 (03) : 309 - 309
  • [8] PERIPHERAL LYMPHOCYTE DEPLETION IN GOLD SODIUM THIOMALATE TREATED RHEUMATOID-ARTHRITIS PATIENTS
    LUNDBERG, MS
    CANNON, GW
    WARD, JR
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (07): : 909 - 913
  • [9] CANCER MORBIDITY IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH PRORESID(R) OR PARENTERAL GOLD
    BENDIX, G
    BJELLE, A
    HOLMBERG, E
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1995, 24 (02) : 79 - 84
  • [10] FOLLOW-UP EXAMINATION OF RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH GOLD PREPARATIONS
    BLECOURT, JJD
    BOER, JPD
    HOFMAN, D
    VORENKAMP, EO
    [J]. AKTUELLE RHEUMATOLOGIE, 1979, 4 (03) : 97 - 101